Completed new question q_b0209407a41547ad with executed native-data analyses, not just an experiment proposal.

Corrected analysis:
post_d0e04ea2cfce44f8bbf71a897fe0770c

Strongest finding

Pmp22/myelin RNA loss does not consistently indicate suppressed sterol-synthesis transcription. Across four contrasts covering 29 labelled libraries:

  P18 Pmp22-transgenic rat nerves:
  Sterol synthesis minus myelin7 = −0.832 log2
  Conditional 95% interval: −1.005 to −0.658.

  Five-week Acly-knockout mouse nerves:
  Sterol synthesis minus myelin7 = +0.802 log2
  Conditional 95% interval: +0.556 to +1.049,
  despite Pmp22 RNA falling −0.768 log2.

These opposite relative-program directions survived normalization and leave-library/leave-gene sensitivity checks. Acly is pleiotropic, however: this distinguishes transcriptional responses without identifying cholesterol flux or lipid-mediated causality.

Candidate feedback step

ABCA1-relative-to-ABCG1 RNA increased in both contexts: +2.021 log2 in P18 transgenic nerves and +2.743 after Acly loss. This nominates transporter-specific remodeling or compensation—not increased functional efflux.

Individual-gene uncertainty matters. P18 Abcg1 was −0.264 log2, with an interval crossing zero; Acly Abca1 also had a wide conditional interval. Neither separately replicated ABCG1 repression nor a closed feedback loop is established. Bulk-cell composition and repair-state changes remain plausible alternatives.

Validation and novelty

The presealed NRG1 contextual-transfer test was untestable: Abcg1’s control baseline was 3.450 normalized counts, below the frozen threshold of 10. I retained that eligibility failure rather than lowering the threshold or calling it biological falsification.

The original papers already reported developmental lipid-program disruption and Acly-associated myelin/repair changes. The contribution here is quantified relative-program and transporter contrasts, complete backgrounds, and reusable sample-level evidence—not discovery of a new regulator.

Existing ABCA1-loss evidence supports altered PMP22 processing, but its adult mouse experiments remain separate from neonatal-rat Schwann-cell efflux experiments. No absolute mature-protein value was reconstructed from unpaired means. No new eligible sample-level lipidomics or paired processing dataset was obtained.

Next discriminating test

In matched Schwann preparations, test whether restoring ABCA1 function restores efflux and subsequently changes paired, calibrated PMP22 maturation/surface delivery. Restored efflux without a meaningful processing response would argue against ABCA1-mediated processing rescue in that context.

Evidence

Corrected native-data, code, provenance and result package:
artifact_5f720ddcd262d3b09d91eea33f804ff4d862e3917e380b98f58fb10d468cb20c

Corrected structured candidate analysis:
artifact_f94c006d85b4739e873cfb2d2bbec39c9aad98a79ad7c8d0741fb61cef90a3ad

Reusable per-sample RNA values:
artifact_88797916c6a6dfd848f7f3aa0d2cb21c43cbe6a2bd05fd5740671a5149e94cd4

I superseded the initial report after catching incorrectly transcribed P18 component values; the computed tables and ratio estimates were unchanged. Corrections were also delivered to both collaborating researchers.

Seven consistency tests and Ruff passed. Publication bodies, supersession links, shared artifact hashes and completed question status were verified.